-The “Movers, Shakers, T1D Changemakers” theme spotlights the impact and influence of individuals making a difference in the T1D Community-

NEW YORK—November 1, 2021—JDRF, the leading global funder of type 1 diabetes (T1D) research, celebrates National Diabetes Awareness Month (NDAM) by honoring changemakers in the T1D community with the “Movers, Shakers, T1D Changemakers” campaign.

“The need for awareness and education on T1D is more important than ever, but we cannot do it alone,” said Aaron J. Kowalski, Ph.D., JDRF CEO. “This National Diabetes Awareness Month, we celebrate the impact and influence of our vast T1D community who together spread awareness about diabetes and highlight the urgent need to accelerate life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications.”

Kicking off the month, JDRF will host its annual fall TypeOne Nation Summit on November 1, 3, and 4th. The three-day virtual event will feature panels about diversity in diabetes, research updates, community forums, and more. On November 3rd, sponsor partners Abbott, Dexcom, Eversense, Gvoke, Medtronic, and Tandem will host T1D product showcases to spotlight new technology available to the market. Guest panelists include Michael Harris, Ph.D. of Oregon Health & Science University, and Bridget Woos, R.D., L.D, CDCES.

On Sunday, November 7th, Team JDRF will take on the New York City Marathon to raise funds and awareness for T1D research.

For more than 50 years, JDRF has been a catalyst of change within the T1D community. JDRF is prioritizing its commitment to increasing education within minority and underserved communities. In partnership with the National Black Leadership Commission on Health, JDRF will co-host a panel on November 12th entitled Understanding Type 1 Diabetes to expand knowledge of T1D within the black and brown community.

To learn more about JDRF Movers, Shakers, T1D Changemakers campaign and other initiatives, please visit https://www.jdrf.org/NDAM/.

For more information about the TypeOne Nation Summit, visit https://www.jdrf.org/community/virtual-connections/.

About JDRF

JDRF’s mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our five international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF

About Type 1 Diabetes (T1D)

T1D is a chronic, life-threatening autoimmune disease that can strike children and adults at any age. It requires rigorous 24/7 monitoring of blood glucose levels—even overnight—to avoid potentially lethal highs and lows in blood sugar, as well as other devastating complications like kidney, eye and nerve diseases. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset is sudden and is not related to diet or lifestyle. In T1D, the body’s immune system destroys cells in the pancreas that produce insulin, meaning the body produces little to no insulin to regulate blood sugar and get energy from food. There is nothing you can do to prevent T1D, and—at present—nothing you can do to get rid of it.